AE Wealth Management’s AbbVie ABBV Stock Holding History

AE Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$1K	–	475
2018 Q3	$1K	Buy	+200	New	+$19K	﹤0.01%	601

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AE Wealth Management's ABBV Position: Q1 2026 in Review

AE Wealth Management increased its AbbVie (ABBV) stake by 12% in Q1 2026, buying an estimated $7.86M and bringing the position to 329,432 shares worth $71.6M. The position accounts for 0.39% of the portfolio, ranked #62.

AE Wealth Management first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

AE Wealth Management held 329,432 shares of AbbVie worth $71.6M as of Q1 2026.
AE Wealth Management bought 35,412 AbbVie shares in Q1 2026, an estimated $7.86M.
AbbVie made up 0.39% of AE Wealth Management's portfolio in Q1 2026, its #62 holding.
AE Wealth Management first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.